Myth Check: Can Lasers Actually Cure Melasma?

Walk down any medical corridor in Beverly Hills and you will find melasma near the top of the consultation list. The condition, which shows up as symmetric brown or gray-brown patches on the cheeks, forehead, and upper lip, disproportionately affects women and people with medium to darker skin tones. It is also stubborn. That combination of visibility and persistence makes it a magnet for laser marketing, and a magnet for disappointment when expectations are set wrong.

The myth: a strong enough laser can erase melasma for good. For an independent overview, see Melasma and pigmentation: diagnosis and treatment.

The reality: melasma is a chronic condition of overactive pigment cells, and lasers manage it rather than cure it.

To understand why, it helps to know what melasma actually is. It is not a stain sitting passively in the skin the way a tattoo is. It is driven by melanocytes, the pigment-producing cells, that have become hyperresponsive to triggers. Ultraviolet light, visible light, heat, hormonal shifts from pregnancy or contraception, and even friction can all tell these cells to produce more melanin. Research over the past decade has added another layer: melasma skin often shows increased blood vessel activity and a damaged basement membrane, the structural layer separating the epidermis from the dermis. That damage lets pigment drop deeper into the skin, where it becomes harder to reach.

A laser can destroy existing pigment. What it cannot do is switch off the biological program telling melanocytes to make more. Worse, because heat itself is a trigger, an aggressive laser treatment can provoke the very cells it is targeting. This is why dermatologists have watched melasma patients get temporarily lighter after an intense treatment, then rebound darker weeks later, a phenomenon sometimes called post-treatment recurrence or rebound hyperpigmentation.

So what do the devices actually do?

The workhorse in most evidence-based melasma protocols is the low-fluence 1064 nanometer Q-switched or picosecond Nd:YAG laser, often called laser toning. The 1064 wavelength penetrates relatively deep and is absorbed less avidly by epidermal melanin than shorter wavelengths, which lowers the risk of injuring surrounding tissue in darker skin. At low fluence, the goal is subcellular: fragmenting melanosomes, the pigment packets inside melanocytes, without killing the cells or generating significant heat. Done in a series, typically weekly or biweekly over two to three months, this can visibly lighten patches.

Picosecond lasers work on a similar principle but deliver energy in pulses roughly one hundred times shorter than nanosecond devices. The shorter pulse shifts the mechanism further toward photoacoustic shattering and away from photothermal heating. In theory that means more pigment fragmentation with less heat, which is why picosecond platforms have become popular for melasma among Beverly Hills practices. Comparative studies show they are effective, though head-to-head data against low-fluence nanosecond treatment shows more modest differences than the marketing suggests.

Nonablative fractional lasers at 1927 nanometers are another tool. Rather than targeting pigment directly, they create microscopic columns of controlled injury that shuttle pigment out of the skin during healing and may help repair the basement membrane. Studies support their use, but the same caution applies: energy settings must stay conservative, because thermal injury can flare the condition.

What the evidence says about durability

Here is the number patients rarely hear in a consultation: recurrence rates after laser treatment for melasma commonly run above fifty percent within six to twelve months when patients stop maintenance therapy. That is not device failure. It is the disease behaving like the chronic condition it is.

The treatments with the strongest long-term evidence remain unglamorous. Rigorous daily use of broad-spectrum, preferably tinted, sunscreen matters because iron oxides in tinted formulas block visible light, which untinted sunscreens do not. Topical agents such as hydroquinone, azelaic acid, and retinoids suppress pigment production at the enzymatic level. Oral tranexamic acid, prescribed off-label in appropriate candidates after screening for clotting risk, reduces the vascular and inflammatory signaling that feeds melasma. In well-designed studies, lasers perform best as an adjunct layered on top of this foundation, not as a replacement for it.

The bottom line for patients

If a consultation promises permanent melasma removal in a package of sessions, treat that as a red flag regardless of the address on the door. A realistic plan sounds different: conservative laser settings, a series rather than a single session, mandatory topical and sun protection homework, and an honest statement that maintenance will be part of life. Melasma responds to management the way a chronic condition does, because that is what it is. The best laser outcome is meaningful, sustained lightening with a plan for the inevitable flare, not a cure that the biology does not permit.

Related reading: Does Laser Really Cure Toenail Fungus? A Myth Check on What the Light Actually Does.